Celiac Disease antibodies

Introduction to Celiac Disease

Celiac Disease is a chronic autoimmune disorder that primarily affects the digestive system, triggered by the ingestion of gluten, a protein found in wheat, barley, and rye. When individuals with Celiac Disease consume gluten, their immune system responds by damaging the small intestine's lining, impairing nutrient absorption and leading to a variety of symptoms such as abdominal pain, bloating, diarrhea, and unexplained weight loss. Beyond gastrointestinal distress, Celiac Disease can also cause anemia, joint pain, and skin rashes, among other symptoms. Research and diagnosis have become increasingly important as Celiac Disease can lead to serious complications if left untreated, including osteoporosis, neurological disorders, and an increased risk of some cancers. The only current effective treatment is a strict, lifelong gluten-free diet. The development of various antibodies has been crucial for advancing diagnostic techniques, allowing for more precise detection of the disease and better understanding of its pathogenesis. These antibodies are essential tools not only in research environments but also in clinical settings to ensure accurate diagnosis and monitoring of patients.

Contents:

1. Celiac Disease Biomarkers
2. Important Mechanisms

Celiac Disease biomarkers

Protein Name	Gene Name	Function
Tissue Transglutaminase (tTG)	TGM2	Enzyme that modifies gluten peptides making them immunogenic; autoantibody target in Celiac Disease.
Transglutaminase 3 (TG3)	TGM3	Transglutaminase enzyme potentially involved in dermatitis herpetiformis, a skin manifestation of Celiac Disease.
Transglutaminase 6 (TG6)	TGM6	Transglutaminase enzyme hypothesized to play a role in neurological manifestations of Celiac Disease.
Villin	VIL1	Structural protein of the brush border; damage measured by antibody levels may correlate with villous atrophy.
Intestinal Fatty Acid Binding Protein (I-FABP)	FABP2	Marker for intestinal epithelial damage; potential biomarker in Celiac Disease.
Glutamate Dehydrogenase	GLUD1	Enzyme that may have increased expression in intestinal damage.
Tumor Necrosis Factor Alpha (TNF-α)	TNF	Pro-inflammatory cytokine, higher levels associated with inflammation in Celiac Disease.
Interleukin 10 (IL-10)	IL10	Anti-inflammatory cytokine, role in counteracting inflammatory response in Celiac Disease.
Interleukin 15 (IL-15)	IL15	Promotes immune response and intestinal epithelial cell destruction in Celiac Disease.
Interferon Gamma (IFN-γ)	IFNG	Key cytokine in the inflammatory response to gluten in Celiac Disease.
Peptidyl-Prolyl Cis-Trans Isomerase	PPIA	Enzyme that may be involved in protein folding and potentially implicated in immune reactions in Celiac Disease.

Important Mechanisms

Genetic Predisposition

Celiac disease, a complex autoimmune disorder, is significantly influenced by genetic factors, primarily involving the human leukocyte antigen (HLA) system. The presence of specific HLA genotypes, such as HLA-DQ2 and HLA-DQ8, is considered crucial for the development of the disease, found in nearly 95% of patients. Research within this sub-area focuses on understanding how these genes influence the immune response to dietary gluten, a key trigger for celiac disease. This necessarily involves delving into the interactions between these genetic markers and other non-HLA genes that might contribute to disease susceptibility. By investigating these genetic pathways, researchers hope to better predict disease risk, understand the variability in clinical manifestations among patients, and potentially pave the way for genetic therapies that could mitigate or even prevent disease onset.

Intestinal Microbiome

An emerging and compelling area of research within celiac disease revolves around the intestinal microbiome— the vast community of microorganisms residing in the human gut. Studies have suggested that the composition and behavior of the gut microbiota play a significant role in the modulation of the immune system and, subsequently, in the pathogenesis of celiac disease. Alterations in the gut microbiome could influence the severity of the disease, and certain bacterial strains might promote or protect against inflammatory responses to gluten. Research in this sub-area seeks to uncover specific microbial profiles associated with celiac disease, explore how dietary elements affect these microbial populations, and understand how microbial-derived compounds can influence intestinal and immune functions. Ultimately, this could lead to probiotic or dietary interventions that might help manage or prevent celiac disease.